ADCC |
Antibody-dependent cell-mediated cytotoxicity |
ACPA |
Anticitrullinated protein antibody |
APRIL |
A proliferating inducing ligand |
BAFF |
B cell activating factor |
BsAb |
Bispecific antibody |
CAR-T cell |
Chimeric antigen receptor T cell |
CAAR-T cell |
Chimeric autoantibody receptor T cell |
CCLE |
Chronic cutaneous lupus erythematosus |
CDC |
Complement-dependent cytotoxicity |
CLE |
Cutaneous lupus erythematosus |
CTLA-4 |
Cytotoxic T lymphocyte-associated protein 4 |
DLE |
Discoid lupus erythematosus |
FDA US |
Food and Drug Administration |
FITC |
Fluorescein isothiocyanate |
FLS |
Fibroblast-like synoviocytes |
GM-CSF |
Granulocyte-macrophage colony-stimulating factor |
JAK |
Janus kinase family |
mAb |
Monoclonal antibody |
SAIDs |
Systemic autoimmune diseases |
SLE |
Systemic lupus erythematosus |
TNF |
Tumor necrosis factor |
RA |
Rheumatoid arthritis |